Author: Kaku S. Yano S. Kawasaki T. Sakai Y. Suzuki K.-i. Kawamura K. Masuho Y. Satoh N. Takenaka T. Landolfi N.F. Man S.C.
Publisher: Elsevier
ISSN: 0306-3623
Source: General Pharmacology, Vol.27, Iss.3, 1996-04, pp. : 435-439
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Kaku S. Kawasaki T. Sakai Y. Taniuchi Y. Yano S. Suzuki K.-i. Terazaki C. Kawamura K. Masuho Y. Satoh N. Takenaka T. Yanagi K. Ohshima N.
European Journal of Pharmacology, Vol. 279, Iss. 2, 1995-06 ,pp. :
Fab Antibody Fragments: Some Applications in Clinical Toxicology
By Robert J. Flanagan Alison L. Jones
Drug Safety, Vol. 27, Iss. 14, 2004-01 ,pp. :
By Vugmeyster Yulia Szklut Pam Wensel David Ross John Xu Xin Awwad Michel Gill Davinder Tchistiakov Lioudmila Warner Garvin
Pharmaceutical Research, Vol. 28, Iss. 7, 2011-07 ,pp. :
Antiplatelet Therapies: Platelet GPIIb / IIIa Antagonists and Beyond
Current Pharmaceutical Design, Vol. 9, Iss. 28, 2003-11 ,pp. :